Press release I Gothenburg, Sweden 08.00 am CET, May 2nd, 2019
The new tissue model kits were developed to provide customers with tissue-specific bioinks and antibodies. The kits include antibodies from Atlas Antibodies, a collaborator with extensive experience in antibody development and production.
CELLINK, the world’s first bioink company and a global leader in bioprinter systems and bioinks, continues innovating new ways to strengthen its position in the field.
Today, CELLINK is announcing the launch of two new tissue model kits — CELLINK SKIN Kit and CELLINK LIVER Kit. These kits give users valuable information about the phenotype of their tissue models. This insight enables better understanding of tissue health and helps researchers develop reliable tissue models for drug screening and cosmetic testing. With this launch, we continue to grow our product portfolio and offer an increasingly extensive range of tools to enhance research worldwide.
These kits are commercially available now through CELLINK and partners. This launch is the first of a multiphase initiative to better serve the needs of our collaborators.